Targeting Batf2 for Infectious Diseases and Cancer

Overview

Journal Oncotarget

Specialty Oncology

Date 2015 Sep 18

PMID 26376615

Citations 21

Authors

Reto Guler

Sugata Roy

Harukazu Suzuki

Frank Brombacher

Affiliations

Soon will be listed here.

Abstract

The family members Batf, Batf2 and Batf3 belong to a class of transcription factors containing basic leucine zipper domains that regulate various immunological functions and control the development and differentiation of immune cells. Functional studies by others demonstrated a predominant role for Batf in controlling Th2 cell functions and lineage development of T lymphocytes as well as a critical role of Batf, Batf2 and Batf3 in CD8α+dendritic cell development. Moreover, Batf family member expression was measured in a vast collection of mouse and human cell types by cap analysis gene expression (CAGE), a recent developed sequencing technology, showing reasonable expression spectrum in immune cells consistent with previously published expression profiles. Batf and Batf3 were highly expressed in lymphocytes and the earlier moderately expressed in myeloid lineages. Batf2 was predominantly expressed in monocytes/macrophages. Functional studies in mice demonstrated that Batf2 has a central role in macrophage activation by regulating inflammatory responses during lipopolysaccharides stimulation and mycobacterial infection. Hence, Batf2 could be used as a biomarker and a potential host directed drug target in tuberculosis. Moreover, Batf2 act as a tumor suppressor gene and augmenting Batf2 in malignant cells might be an encouraging therapeutic treatment against cancer.

Citing Articles

Specific human gene expression in response to infection is an effective marker for diagnosis of latent and active tuberculosis.

Nakiboneka R, Walbaum N, Musisi E, Nevels M, Nyirenda T, Nliwasa M Sci Rep. 2024; 14(1):26884.

PMID: 39505948 PMC: 11541504. DOI: 10.1038/s41598-024-77164-5.

Changes in the Transcriptome and Long Non-Coding RNAs but Not the Methylome Occur in Human Cells Exposed to .

Berthold A, Lloyd V Genes (Basel). 2024; 15(8).

PMID: 39202370 PMC: 11353914. DOI: 10.3390/genes15081010.

ABBV-744 alleviates LPS-induced neuroinflammation via regulation of BATF2-IRF4-STAT1/3/5 axis.

Wang L, Wang H, Lin S, Xu X, Hu W, Liu J Acta Pharmacol Sin. 2024; 45(10):2077-2091.

PMID: 38862817 PMC: 11420366. DOI: 10.1038/s41401-024-01318-4.

BATF2 enhances proinflammatory cytokine responses in macrophages and improves early host defense against pulmonary infection.

van der Geest R, Penaloza H, Xiong Z, Gonzalez-Ferrer S, An X, Li H Am J Physiol Lung Cell Mol Physiol. 2023; 325(5):L604-L616.

PMID: 37724373 PMC: 11068429. DOI: 10.1152/ajplung.00441.2022.

Immune response modulation in inflammatory bowel diseases by infection.

Feilstrecker Balani G, Dos Santos Cortez M, Picasky da Silveira Freitas J, de Melo F, Zarpelon-Schutz A, Teixeira K World J Gastroenterol. 2023; 29(30):4604-4615.

PMID: 37662864 PMC: 10472898. DOI: 10.3748/wjg.v29.i30.4604.

References

Liu Z, Wei P, Yang Y, Cui W, Cao B, Tan C . BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs. Clin Cancer Res. 2015; 21(7):1752-63. DOI: 10.1158/1078-0432.CCR-14-1564. View

Wang C, Su Y, Zhang L, Wang M, You J, Zhao X . The function of SARI in modulating epithelial-mesenchymal transition and lung adenocarcinoma metastasis. PLoS One. 2012; 7(9):e38046. PMC: 3458851. DOI: 10.1371/journal.pone.0038046. View

Rajaram M, Ni B, Dodd C, Schlesinger L . Macrophage immunoregulatory pathways in tuberculosis. Semin Immunol. 2014; 26(6):471-85. PMC: 4314327. DOI: 10.1016/j.smim.2014.09.010. View

Iacobelli M, Wachsman W, McGuire K . Repression of IL-2 promoter activity by the novel basic leucine zipper p21SNFT protein. J Immunol. 2000; 165(2):860-8. DOI: 10.4049/jimmunol.165.2.860. View

Vilaplana C, Marzo E, Tapia G, Diaz J, Garcia V, Cardona P . Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis. J Infect Dis. 2013; 208(2):199-202. DOI: 10.1093/infdis/jit152. View

Walker N, Clark S, Oni T, Andreu N, Tezera L, Singh S . Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases. Am J Respir Crit Care Med. 2012; 185(9):989-97. PMC: 3359940. DOI: 10.1164/rccm.201110-1769OC. View

Singhal A, Jie L, Kumar P, Hong G, Leow M, Paleja B . Metformin as adjunct antituberculosis therapy. Sci Transl Med. 2014; 6(263):263ra159. DOI: 10.1126/scitranslmed.3009885. View

Skerry C, Harper J, Klunk M, Bishai W, Jain S . Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas. PLoS One. 2012; 7(6):e39680. PMC: 3384606. DOI: 10.1371/journal.pone.0039680. View

Rayasam G, Balganesh T . Exploring the potential of adjunct therapy in tuberculosis. Trends Pharmacol Sci. 2015; 36(8):506-13. DOI: 10.1016/j.tips.2015.05.005. View

10.

Forrest A, Kawaji H, Rehli M, Baillie J, de Hoon M, Haberle V . A promoter-level mammalian expression atlas. Nature. 2014; 507(7493):462-70. PMC: 4529748. DOI: 10.1038/nature13182. View

11.

Skerry C, Pinn M, Bruiners N, Pine R, Gennaro M, Karakousis P . Simvastatin increases the in vivo activity of the first-line tuberculosis regimen. J Antimicrob Chemother. 2014; 69(9):2453-7. PMC: 4184365. DOI: 10.1093/jac/dku166. View

12.

Maiga M, Ammerman N, Maiga M, Tounkara A, Siddiqui S, Polis M . Adjuvant host-directed therapy with types 3 and 5 but not type 4 phosphodiesterase inhibitors shortens the duration of tuberculosis treatment. J Infect Dis. 2013; 208(3):512-9. PMC: 3699007. DOI: 10.1093/infdis/jit187. View

13.

Rajaram M, Brooks M, Morris J, Torrelles J, Azad A, Schlesinger L . Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses. J Immunol. 2010; 185(2):929-42. PMC: 3014549. DOI: 10.4049/jimmunol.1000866. View

14.

Parihar S, Guler R, Khutlang R, Lang D, Hurdayal R, Mhlanga M . Statin therapy reduces the mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation. J Infect Dis. 2013; 209(5):754-63. DOI: 10.1093/infdis/jit550. View

15.

Glasmacher E, Agrawal S, Chang A, Murphy T, Zeng W, Vander Lugt B . A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science. 2012; 338(6109):975-80. PMC: 5789805. DOI: 10.1126/science.1228309. View

16.

Iannaccone M, Dorhoi A, Kaufmann S . Host-directed therapy of tuberculosis: what is in it for microRNA?. Expert Opin Ther Targets. 2014; 18(5):491-4. DOI: 10.1517/14728222.2014.897696. View

17.

Ma H, Liang X, Chen Y, Pan K, Sun J, Wang H . Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma. Int J Cancer. 2010; 128(4):771-7. DOI: 10.1002/ijc.25407. View

18.

Gutierrez M, Master S, Singh S, Taylor G, Colombo M, Deretic V . Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell. 2004; 119(6):753-66. DOI: 10.1016/j.cell.2004.11.038. View

19.

Su Z, Lee S, Emdad L, Lebdeva I, Gupta P, Valerie K . Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN). Proc Natl Acad Sci U S A. 2008; 105(52):20906-11. PMC: 2634918. DOI: 10.1073/pnas.0807975106. View

20.

Yogalingam G, Pendergast A . Abl kinases regulate autophagy by promoting the trafficking and function of lysosomal components. J Biol Chem. 2008; 283(51):35941-53. PMC: 2602914. DOI: 10.1074/jbc.M804543200. View